Trial Profile
Efficacy of Long-term Telbivudine Treatment on Histological Improvements in Patients With Chronic Hepatitis B (EFFORT Further Extension Study)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms EFFORT 3; EFFORT Further Extension Study
- 25 Mar 2020 Results published in the Journal of Infectious Diseases
- 15 Jul 2016 New trial record